FOXO Tech board approves spin-off of epigenetics subsidiary FOXO Labs

FOXO TECHNOLOGIES INC.

Board approved pursuing spin-off of FOXO Labs, Inc., its epigenetics subsidiary; FOXO shareholders to directly own shares in the new entity.
FOXO will retain some ownership in the spun-off company while simplifying each entity's business model.
FOXO Labs owns patent for machine learning model using DNA epigenetic data; focuses on saliva-based biomarker testing for health/longevity.
Spin-off intended to create subscription-based revenue model for personal health and longevity coaching using AI and epigenetic analysis.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.